tiprankstipranks
Trending News
More News >
Globus Medical (GMED)
NYSE:GMED
US Market

Globus Medical (GMED) Ratios

Compare
952 Followers

Globus Medical Ratios

GMED's free cash flow for Q3 2025 was $0.63. For the 2025 fiscal year, GMED's free cash flow was decreased by $ and operating cash flow was $0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
4.13 2.54 4.88 6.18 6.17
Quick Ratio
2.47 1.77 2.72 4.30 4.48
Cash Ratio
0.80 0.92 1.19 0.95 1.38
Solvency Ratio
1.00 0.33 0.25 1.12 1.01
Operating Cash Flow Ratio
1.53 0.61 0.62 1.12 1.97
Short-Term Operating Cash Flow Coverage
49.82 1.17 0.00 0.00 0.00
Net Current Asset Value
$ 1.23B$ 1.10B$ 827.25M$ 753.59M$ 648.64M
Leverage Ratios
Debt-to-Assets Ratio
0.02 0.10 0.10 <0.01 <0.01
Debt-to-Equity Ratio
0.03 0.13 0.13 <0.01 <0.01
Debt-to-Capital Ratio
0.03 0.11 0.12 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.09 0.00 0.00
Financial Leverage Ratio
1.16 1.26 1.27 1.12 1.12
Debt Service Coverage Ratio
44.91 1.02 0.00 17.68 23.56
Interest Coverage Ratio
452.02 39.63 0.00 16.02 18.50
Debt to Market Cap
<0.01 0.04 0.07 0.00 0.00
Interest Debt Per Share
0.89 3.99 4.60 0.20 0.14
Net Debt to EBITDA
-0.35 -0.52 0.15 -0.47 -0.75
Profitability Margins
Gross Profit Margin
64.26%58.90%65.05%74.22%75.03%
EBIT Margin
15.95%8.72%12.87%23.10%18.83%
EBITDA Margin
25.92%18.80%22.10%29.77%26.12%
Operating Profit Margin
13.30%6.59%8.49%22.29%17.95%
Pretax Profit Margin
16.63%4.79%10.54%23.76%18.83%
Net Profit Margin
15.30%4.09%7.83%18.59%15.57%
Continuous Operations Profit Margin
15.30%4.09%7.83%18.59%15.57%
Net Income Per EBT
92.03%85.31%74.29%78.25%82.70%
EBT Per EBIT
125.00%72.73%124.22%106.61%104.92%
Return on Assets (ROA)
8.32%1.96%2.42%9.16%7.62%
Return on Equity (ROE)
9.99%2.47%3.07%10.30%8.57%
Return on Capital Employed (ROCE)
7.96%3.78%2.84%11.89%9.46%
Return on Invested Capital (ROIC)
7.30%2.92%2.10%9.29%7.83%
Return on Tangible Assets
14.68%3.41%4.51%10.48%8.73%
Earnings Yield
3.47%0.92%2.04%2.55%2.05%
Efficiency Ratios
Receivables Turnover
4.03 4.36 3.11 4.71 5.78
Payables Turnover
11.35 13.78 9.67 7.31 10.90
Inventory Turnover
1.28 1.57 0.65 0.88 1.01
Fixed Asset Turnover
4.35 4.12 2.42 4.20 4.33
Asset Turnover
0.54 0.48 0.31 0.49 0.49
Working Capital Turnover Ratio
2.00 1.77 1.34 1.32 1.34
Cash Conversion Cycle
342.98 289.68 644.48 441.38 391.22
Days of Sales Outstanding
90.68 83.79 117.49 77.55 63.11
Days of Inventory Outstanding
284.46 232.38 564.73 413.79 361.61
Days of Payables Outstanding
32.16 26.48 37.73 49.96 33.50
Operating Cycle
375.14 316.16 682.22 491.34 424.72
Cash Flow Ratios
Operating Cash Flow Per Share
5.32 3.84 2.15 1.78 2.74
Free Cash Flow Per Share
4.31 2.99 1.46 1.04 2.18
CapEx Per Share
1.01 0.85 0.69 0.74 0.56
Free Cash Flow to Operating Cash Flow
0.81 0.78 0.68 0.59 0.79
Dividend Paid and CapEx Coverage Ratio
5.27 4.51 3.11 2.41 4.86
Capital Expenditure Coverage Ratio
5.27 4.51 3.11 2.41 4.86
Operating Cash Flow Coverage Ratio
5.99 0.97 0.47 29.69 54.68
Operating Cash Flow to Sales Ratio
0.26 0.21 0.16 0.17 0.29
Free Cash Flow Yield
4.78%3.61%2.74%1.40%3.02%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
28.78 109.01 49.05 39.24 48.75
Price-to-Sales (P/S) Ratio
4.38 4.46 3.84 7.30 7.59
Price-to-Book (P/B) Ratio
2.77 2.69 1.51 4.04 4.18
Price-to-Free Cash Flow (P/FCF) Ratio
20.94 27.70 36.47 71.46 33.15
Price-to-Operating Cash Flow Ratio
17.05 21.56 24.75 41.81 26.33
Price-to-Earnings Growth (PEG) Ratio
1.51 -3.60 -1.16 1.42 1.15
Price-to-Fair Value
2.77 2.69 1.51 4.04 4.18
Enterprise Value Multiple
16.55 23.18 17.54 24.03 28.31
Enterprise Value
11.88B 10.98B 6.08B 7.32B 7.08B
EV to EBITDA
16.55 23.18 17.54 24.03 28.31
EV to Sales
4.29 4.36 3.88 7.15 7.39
EV to Free Cash Flow
20.50 27.09 36.80 70.08 32.30
EV to Operating Cash Flow
16.62 21.09 24.97 41.00 25.64
Tangible Book Value Per Share
16.29 14.37 14.49 15.78 14.82
Shareholders’ Equity Per Share
32.70 30.78 35.35 18.38 17.29
Tax and Other Ratios
Effective Tax Rate
0.08 0.15 0.26 0.22 0.17
Revenue Per Share
20.59 18.56 13.87 10.18 9.51
Net Income Per Share
3.15 0.76 1.09 1.89 1.48
Tax Burden
0.92 0.85 0.74 0.78 0.83
Interest Burden
1.04 0.55 0.82 1.03 1.00
Research & Development to Revenue
0.05 0.06 0.08 0.07 0.10
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.03 0.03 0.03
Income Quality
1.69 5.06 1.98 0.94 1.85
Currency in USD